Solid Biosciences Inc. — Director's Dealing 2023

Sep 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2023-09-02

Reporting Person: Ganot Ilan (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-02	Common Stock	M	1583	—	Acquired	89341	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-02	Restricted Stock Units	$	M	1583	Disposed		Common Stock (1583)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19394	Indirect
Common Stock	4323	Indirect

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Represents 85,299 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F3: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F4: Includes 1,879 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2023.

F5: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.